CompoAtlas

ARKORELAX SOMMEIL FAMILLE, flacon

Food supplement declared in France, decision dated 10 November 2025

ARKORELAX SOMMEIL FAMILLE, flacon (ARKOPHARMA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Matricaria chamomilla 800 mg per day, Tilia tomentosa 412 mg per day, Papaver rhoeas 90 mg per day, Aloysia citriodora 5.82 g per day. None of the rules we check flags an issue with its declared composition.

Brand
ARKOPHARMA
Food business operator placing the product on the market
LABORATOIRES ARKOPHARMA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
20 ml
Directions for use
De 1-3 ans : 5 ml / De 4-6 ans : 7,5 ml / De 7-11 ans : 10 ml / Dès 12 ans : 20 ml
Intended populations
Young children aged 1 to 3, Children aged 4 to 10, Adolescents aged 11 to 17, Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women, Infants (under 1 year)
Objectives stated by the manufacturer (these are not authorised claims)
Respiratory tract, Digestion, Sleep
Flavourings
Fraine-Banane

Declaration 343762, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Matricaria chamomilla L.FleurExtrait sec aqueux800 mg
Tilia tomentosa MoenchFleurExtrait sec aqueux412 mg
Papaver rhoeas L.FleurExtrait sec aqueux90 mg
Aloysia citriodora PalauFeuilleExtrait fluide aqueux5.82 g

Other ingredients

jus de citron, maltodextrine, sirop d'agave, sirop de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Enfants à partir d’1 an. Déconseillé en cas d'allergie aux plantes de la famille des Astéracées. En cas de sommeil difficile chez un enfant de 1 à 3 ans, ou de traitement médicamenteux, il est recommandé de demander l’avis d’un professionnel de santé.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Matricaria chamomilla L.
    Read the warning, when it applies and the studies cited

    GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000; WHO 1999; Bradley 1992).

    Cautions and warnings

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. 2003. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Health Canada monograph dated 19 December 2025

    German Chamomile - Matricaria Chamomilla Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 31 January 2025

    GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Buccal

    Route of administration: Buccal (ESCOP 2003; Blumenthal et al. 2000; Bradley 1992)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : ARKOPHARMA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “ARKORELAX SOMMEIL FAMILLE, flacon (ARKOPHARMA): composition and regulation”, https://compoatlas.com/en/supplements/products/343762-arkorelax-sommeil-famille-flacon, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line